Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting EMT in cancer: opportunities for pharmacological intervention
Felicity M. Davis, Teneale A. Stewart, Erik W. Thompson, et al.
Trends in Pharmacological Sciences (2014) Vol. 35, Iss. 9, pp. 479-488
Open Access | Times Cited: 314

Showing 26-50 of 314 citing articles:

Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy
Jeffrey C. Thompson, Wei‐Ting Hwang, Christiana Davis, et al.
Lung Cancer (2019) Vol. 139, pp. 1-8
Open Access | Times Cited: 120
Small molecule inhibitors of epithelial‐mesenchymal transition for the treatment of cancer and fibrosis
Ya‐Long Feng, Dan‐Qian Chen, Nosratola D. Vaziri, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 1, pp. 54-78
Open Access | Times Cited: 113
Targeting DNA damage repair in small cell lung cancer and the biomarker landscape
Triparna Sen, Carl M. Gay, Lauren A. Byers
Translational Lung Cancer Research (2018) Vol. 7, Iss. 1, pp. 50-68
Open Access | Times Cited: 112
Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non–small cell lung cancer
Kazuhiko Shien, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba
Lung Cancer (2016) Vol. 99, pp. 79-87
Open Access | Times Cited: 110
The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1
Yanyan Gao, Yaping Zhao, Juechao Zhang, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 105
Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer
Venkatrao Vantaku, Jianrong Dong, Chandrashekar R. Ambati, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 12, pp. 3689-3701
Open Access | Times Cited: 103
circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m6A-YTHDF3-Zeb1
Maoyu Wang, Yongliang Yang, Jing Yang, et al.
Life Sciences (2020) Vol. 257, pp. 118082-118082
Closed Access | Times Cited: 96
Inhibition of BRD4 suppresses the malignancy of breast cancer cells via regulation of Snail
Linlin Lu, Zhuojia Chen, Xinyao Lin, et al.
Cell Death and Differentiation (2019) Vol. 27, Iss. 1, pp. 255-268
Open Access | Times Cited: 95
HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer
Xueting Hu, Wei Xing, Rong-sen Zhao, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 92
ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
Takeshi Yoshida, Lanxi Song, Yun Bai, et al.
PLoS ONE (2016) Vol. 11, Iss. 1, pp. e0147344-e0147344
Open Access | Times Cited: 91
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
Anna Wawruszak, Joanna Kałafut, Estera Okoń, et al.
Cancers (2019) Vol. 11, Iss. 2, pp. 148-148
Open Access | Times Cited: 90
The Calcium-Signaling Toolkit in Cancer: Remodeling and Targeting
Sarah J. Roberts‐Thomson, Silke B. Chalmers, Gregory R. Monteith
Cold Spring Harbor Perspectives in Biology (2019) Vol. 11, Iss. 8, pp. a035204-a035204
Open Access | Times Cited: 84
Tumor metastasis: Mechanistic insights and therapeutic interventions
Mengmeng Liu, Jing Yang, Bu-Shu Xu, et al.
MedComm (2021) Vol. 2, Iss. 4, pp. 587-617
Open Access | Times Cited: 77
In Vitro 3D Cultures to Model the Tumor Microenvironment
Fabrizio Fontana, Monica Marzagalli, Michele Sommariva, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2970-2970
Open Access | Times Cited: 66
NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype
Amy Oh, Makayla Pardo, Anaelena Rodriguez, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 36
Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
Yuanzhuo Gu, Zhengkui Zhang, Peter ten Dijke
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 4, pp. 318-340
Open Access | Times Cited: 31
Clinical impact of epithelial–mesenchymal transition for cancer therapy
Nobendu Mukerjee, Sagnik Nag, Bikramjit Bhattacharya, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 11
Anti-Inflammatory and Anti-Migratory Effects of Morin on Non-Small-Cell Lung Cancer Metastasis via Inhibition of NLRP3/MAPK Signaling Pathway
Punnida Arjsri, Kamonwan Srisawad, Sonthaya Umsumarng, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 103-103
Open Access | Times Cited: 1
A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer
Zachary A. Yochum, Jessica Cades, Lucia Mazzacurati, et al.
Molecular Cancer Research (2017) Vol. 15, Iss. 12, pp. 1764-1776
Open Access | Times Cited: 78
Addressing intra-tumoral heterogeneity and therapy resistance
Brad Rybinski, Kyuson Yun
Oncotarget (2016) Vol. 7, Iss. 44, pp. 72322-72342
Open Access | Times Cited: 77
Tumor Budding and Prognosis in Gastric Adenocarcinoma
Niko Kemi, Maarit Eskuri, Julia Ikäläinen, et al.
The American Journal of Surgical Pathology (2018) Vol. 43, Iss. 2, pp. 229-234
Open Access | Times Cited: 73
Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond
Shao Thing Teoh, Sophia Y. Lunt
WIREs Systems Biology and Medicine (2017) Vol. 10, Iss. 2
Open Access | Times Cited: 69
O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis
Kekoa Taparra, Hailun Wang, Reem Malek, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 11, pp. 4924-4937
Open Access | Times Cited: 69
Erratum: MicroRNA-338-3p suppresses metastasis of lung cancer cells by targeting the EMT regulator Sox4.
Yang Li, Peirui Chen, Lingling Zu, et al.
PubMed (2016) Vol. 6, Iss. 7, pp. 1582-1582
Closed Access | Times Cited: 65
miR-210-5p promotes epithelial–mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells
Wei Liu, Dongdong Jiang, Fangyi Gong, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 2
Open Access | Times Cited: 58

Scroll to top